Clinical Trial Update: Study Confirming A Human Challenge Model and Investigating The Safety Of VLA1701 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on the safety of VLA1701 in an established human challenge model for Enterotoxigenic Escherichia coli infection; results posted af…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diarrhea
• Enterotoxigenic Escherichia Coli Infection

Drugs mentioned

• VLA1701

Snippet

Sponsor: Valneva Austria GmbH | Conditions: Enterotoxigenic Escherichia Coli Infection, Diarrhea | Phase 2 | Status: COMPLETED | Results posted: 2021-04-23